Total Funding
58
52
Total FundingGrant raised
Growth Score
-4 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
145766
Respinova is develops treatments for COPD and respiratory diseases.
- Noam Gavriely: CMO
- Yuval Avni: CTO
About the Company
Respinova provides pulmonary treatment devices. It develops a novel non-invasive technology, PulseHaler, that treats the core of COPD pathophysiology. They serve COPD patients. Their Pulsehaler is a novel treatment that uses dynamic air pressure pulses to facilitate the opening of airways and the clearance of mucus.
